Capital International Investors
AZN icon

Capital International Investors’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.19B Buy
31,404,983
+119,423
+0.4% +$8.34M 0.38% 64
2025
Q1
$2.3B Sell
31,285,560
-6,221,599
-17% -$458M 0.45% 58
2024
Q4
$2.46B Buy
37,507,159
+686,008
+2% +$45M 0.46% 56
2024
Q3
$2.87B Buy
36,821,151
+117,433
+0.3% +$9.14M 0.55% 49
2024
Q2
$2.86B Buy
36,703,718
+2,181,843
+6% +$170M 0.59% 46
2024
Q1
$2.34B Sell
34,521,875
-260,887
-0.8% -$17.7M 0.47% 61
2023
Q4
$2.34B Buy
34,782,762
+164,183
+0.5% +$11.1M 0.53% 53
2023
Q3
$2.34B Sell
34,618,579
-3,721,186
-10% -$252M 0.59% 43
2023
Q2
$2.74B Buy
38,339,765
+211,055
+0.6% +$15.1M 0.66% 34
2023
Q1
$2.65B Sell
38,128,710
-2,669,638
-7% -$185M 0.68% 34
2022
Q4
$2.77B Buy
40,798,348
+472,725
+1% +$32.1M 0.74% 31
2022
Q3
$2.21B Buy
40,325,623
+942,624
+2% +$51.7M 0.65% 38
2022
Q2
$2.61B Buy
39,382,999
+2,389,335
+6% +$158M 0.71% 36
2022
Q1
$2.46B Buy
36,993,664
+1,604,875
+5% +$107M 0.56% 47
2021
Q4
$2.06B Buy
35,388,789
+555,607
+2% +$32.4M 0.44% 59
2021
Q3
$2.09B Buy
34,833,182
+2,783,859
+9% +$167M 0.48% 55
2021
Q2
$1.92B Buy
32,049,323
+1,935,945
+6% +$116M 0.44% 62
2021
Q1
$1.5B Buy
30,113,378
+4,124,723
+16% +$205M 0.38% 75
2020
Q4
$1.3B Sell
25,988,655
-3,260,811
-11% -$163M 0.35% 80
2020
Q3
$1.6B Sell
29,249,466
-589,160
-2% -$32.3M 0.5% 52
2020
Q2
$1.58B Buy
29,838,626
+1,513,006
+5% +$80M 0.52% 47
2020
Q1
$1.27B Buy
28,325,620
+5,375,926
+23% +$240M 0.52% 47
2019
Q4
$1.14B Buy
22,949,694
+6,319,420
+38% +$315M 0.39% 79
2019
Q3
$741M Buy
16,630,274
+3,500
+0% +$156K 0.28% 102
2019
Q2
$686M Buy
16,626,774
+5,375,863
+48% +$222M 0.27% 99
2019
Q1
$455M Buy
11,250,911
+846
+0% +$34.2K 0.2% 126
2018
Q4
$427M Buy
11,250,065
+1,497,478
+15% +$56.9M 0.21% 120
2018
Q3
$386M Buy
9,752,587
+319,416
+3% +$12.6M 0.18% 136
2018
Q2
$331M Buy
9,433,171
+256
+0% +$8.99K 0.37% 95
2018
Q1
$330M Sell
9,432,915
-533,495
-5% -$18.7M 0.38% 91
2017
Q4
$346M Sell
9,966,410
-1,300
-0% -$45.1K 0.39% 84
2017
Q3
$338M Sell
9,967,710
-6,597,100
-40% -$224M 0.4% 81
2017
Q2
$565M Sell
16,564,810
-1,946,789
-11% -$66.4M 0.75% 40
2017
Q1
$576M Buy
18,511,599
+542,800
+3% +$16.9M 0.78% 38
2016
Q4
$491M Sell
17,968,799
-2,631,380
-13% -$71.9M 0.71% 43
2016
Q3
$677M Buy
20,600,179
+126,700
+0.6% +$4.16M 0.98% 28
2016
Q2
$618M Buy
20,473,479
+3,705,199
+22% +$112M 0.91% 33
2016
Q1
$472M Buy
16,768,280
+506,900
+3% +$14.3M 0.72% 40
2015
Q4
$552M Buy
16,261,380
+16,400
+0.1% +$557K 0.85% 35
2015
Q3
$517M Buy
16,244,980
+9,781,890
+151% +$311M 0.94% 29
2015
Q2
$412M Buy
6,463,090
+2,427,200
+60% +$155M 0.7% 40
2015
Q1
$276M Buy
4,035,890
+2,066,500
+105% +$141M 0.5% 69
2014
Q4
$139M Buy
1,969,390
+406,730
+26% +$28.6M 0.28% 102
2014
Q3
$112M Buy
1,562,660
+1,660
+0.1% +$119K 0.27% 107
2014
Q2
$116M Buy
1,561,000
+2,800
+0.2% +$208K 0.3% 105
2014
Q1
$101M Hold
1,558,200
0.27% 115
2013
Q4
$92.5M Buy
+1,558,200
New +$92.5M 0.29% 113